Who owns Parabilis Medicines, Inc.? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under FOG PHARMACEUTICALS, INC. in our court records and SEC 8-K records (as of 2026-10-18).
• Leadership changes: the latest reported is Craig Tendler, Director (Form 8-K filed 2026-08-25). Check you are dealing with the people now in charge.
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Arch Venture Fund Xii, L.P. (filed 2026-08-14).

Who is behind it

Parabilis Medicines, Inc.: incorporated in Delaware; business address in Cambridge, Massachusetts; industry Pharmaceutical Preparations (Form D, 2026-08-25).

Officers and directors, each with the role and the filing that names them:

• Gregory L. Verdine: Executive Officer, Director (Form D, 2022-12-02)
• Jeffrey A. Leerink: Director (Form D, 2022-12-02)
• Edward M. Fitzgerald: Director (Form D, 2022-12-02)
• WeiQing Zhou: Executive Officer (Form D, 2022-12-02)
• Krishna Yeshwant: Director (Form D, 2022-12-02)
• Barbara Weber: Director (Form D, 2022-12-02)
• Rick Klausner: Director (Form D, 2022-12-02)
• Corey S. Goodman: Director (Form D, 2022-12-02)

Money raised

Latest IPO step: Parabilis Medicines, Inc. filed its final IPO prospectus, ticker PBLS (424B4, 2026-06-10).

IPO filings: 424B4, 2026-06-10, S-1/A, 2026-06-09, S-1/A, 2026-06-04, S-1/A, 2026-05-27, S-1, 2026-05-19; ticker PBLS on Nasdaq Global Select Market.

Related pages

Leadership changes5%+ holdersIPO filings

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.